Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mass. Medicaid To Establish Quantity Limit For Short-Acting Beta-2 Agonists

Executive Summary

Massachusetts Medicaid will establish a quantity limit for short-acting beta-2 agonists to encourage physicians to alter "inadequate" anti-inflammatory therapy
Advertisement

Related Content

Mass. Medicaid Advises Against Zyprexa First Line, But No Prior Authorization
Mass. Medicaid Leukotriene Blocker Limitation Seeks To Curb Allergy Use
Mass. Medicaid Leukotriene Blocker Limitation Seeks To Curb Allergy Use
Advertisement
UsernamePublicRestriction

Register

PS042431

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel